End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.8 CNY | +2.38% | -2.04% | -11.82% |
11:14am | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
05:50am | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
Sales 2024 * | 3.92B 541M | Sales 2025 * | 4.74B 654M | Capitalization | 31.43B 4.34B |
---|---|---|---|---|---|
Net income 2024 * | 687M 94.8M | Net income 2025 * | 839M 116M | EV / Sales 2024 * | 7.2 x |
Net cash position 2024 * | 3.2B 441M | Net cash position 2025 * | 3.18B 438M | EV / Sales 2025 * | 5.96 x |
P/E ratio 2024 * |
48.3
x | P/E ratio 2025 * |
38.9
x | Employees | 3,517 |
Yield 2024 * |
1.84% | Yield 2025 * |
1.51% | Free-Float | 38.31% |
1 day | +2.38% | ||
1 week | -2.04% | ||
Current month | -1.06% | ||
1 month | +3.86% | ||
3 months | +5.11% | ||
6 months | +1.16% | ||
Current year | -11.82% |
Managers | Title | Age | Since |
---|---|---|---|
Jie Yan
CEO | Chief Executive Officer | 51 | 05-12-31 |
Ai Zhen Li
CHM | Chairman | 54 | 04-02-29 |
Yun Kong
DFI | Director of Finance/CFO | 51 | 21-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Hai Ye
BRD | Director/Board Member | 80 | 98-11-02 |
Sing Ye
CHM | Chairman | 49 | 04-06-30 |
Jian Feng Yang
BRD | Director/Board Member | 48 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.63% | 2 M€ | -20.02% | - | |
0.46% | 2 M€ | -14.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 28.8 | +2.38% | 3,833,716 |
24-04-19 | 28.13 | -2.36% | 4,520,709 |
24-04-18 | 28.81 | -0.35% | 2,769,126 |
24-04-17 | 28.91 | +0.38% | 3,185,464 |
24-04-16 | 28.8 | -2.04% | 4,083,569 |
End-of-day quote Shenzhen S.E., April 21, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.82% | 4.34B | |
+17.94% | 44.31B | |
+19.87% | 22.17B | |
+15.48% | 14.62B | |
+8.00% | 13.12B | |
+39.35% | 11.58B | |
-8.96% | 6.96B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.50% | 5.03B |
- Stock Market
- Equities
- 002294 Stock